SWM
CVS icon

Silverlake Wealth Management’s CVS Health CVS Stock Holding History

Silverlake Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$844K Sell
8,159
-104
-1% -$9.28K 0.16% 163
2026
Q1 		$593K Buy
8,263
+25
+0.3% +$1.93K 0.12% 184
2025
Q4 		$654K Buy
8,238
+27
+0.3% +$2.13K 0.15% 162
2025
Q3 		$619K Buy
8,211
+33
+0.4% +$2.26K 0.15% 155
2025
Q2 		$564K Sell
8,178
-1,909
-19% -$125K 0.16% 148
2025
Q1 		$683K Sell
10,087
-731
-7% -$43.7K 0.26% 106
2024
Q4 		$486K Sell
10,818
-2,646
-20% -$148K 0.19% 134
2024
Q3 		$847K Sell
13,464
-146
-1% -$8.52K 0.32% 87
2024
Q2 		$804K Buy
13,610
+2,407
+21% +$151K 0.33% 84
2024
Q1 		$894K Buy
11,203
+173
+2% +$13.2K 0.45% 56
2023
Q4 		$871K Sell
11,030
-2,425
-18% -$173K 0.48% 53
2023
Q3 		$939K Buy
13,455
+365
+3% +$25.9K 0.53% 48
2023
Q2 		$905K Buy
13,090
+3,980
+44% +$283K 0.5% 50
2023
Q1 		$677K Sell
9,110
-97
-1% -$8.13K 0.41% 63
2022
Q4 		$858K Buy
9,207
+237
+3% +$22.9K 0.54% 49
2022
Q3 		$855K Buy
8,970
+19
+0.2% +$1.88K 0.58% 43
2022
Q2 		$829K Buy
8,951
+18
+0.2% +$1.76K 0.54% 50
2022
Q1 		$904K Sell
8,933
-548
-6% -$57.6K 0.52% 55
2021
Q4 		$978K Buy
+9,481
New +$876K 0.53% 53

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Silverlake Wealth Management's CVS Position: Q2 2026 in Review

Silverlake Wealth Management reduced its CVS Health (CVS) stake by 1.3% in Q2 2026, selling an estimated $9.28K and leaving 8,159 shares worth $844K. The position accounts for 0.16% of the portfolio, ranked #163.

Silverlake Wealth Management first reported a position in CVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $978K in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Silverlake Wealth Management held 8,159 shares of CVS Health worth $844K as of Q2 2026.
  • Silverlake Wealth Management sold 104 CVS Health shares in Q2 2026, an estimated $9.28K.
  • CVS Health made up 0.16% of Silverlake Wealth Management's portfolio in Q2 2026, its #163 holding.
  • Silverlake Wealth Management first reported a position in CVS Health in Q4 2021 and has held it in 19 quarters since.
  • Silverlake Wealth Management's CVS Health position peaked at $978K in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Silverlake Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.